1 story on this topic, newest first.
Abbott received FDA clearance for the Libre Duo, a single 10-day arm sensor that tracks both glucose and ketone levels simultaneously. The wearable streams real-time data to a smartphone, warning users of dangerous metabolic spikes before diabetic ketoacidosis can take hold.